Search This Blog

Thursday, June 1, 2023

3 New China-Russia-Iran And Iraq Agreements Confirm The New Oil Market Order

 by Simon Watkins via OilPrice.com,

  • Moscow signed 10 new cooperation agreements with Iran for the oil sector alone on 18 May.

  • China waited for the dust to settle before it too signed new cooperation agreements with Iran on 23 May.

  • China has significantly expanded its influence in the Middle East in order to secure sufficient hydrocarbon supplies to fuel its economic growth.

The last week or so has seen a flurry of major cooperation agreements - including in energy, security, and logistics – between various permutations of Iran, Iraq, Russia, and China. Like a very dark version of the old U.S. soap opera parody ‘Soap’ this real-life version is equally convoluted, albeit a lot less funny. Its key elements constitute a significant part of the new global oil market order, which is analysed in depth in my new book on the subject, but the three most recent principal cooperation agreements will have immediate consequences for oil and gas flows around the world and their pricing.

The best place to start here is at the end point of what China wants in its grand scheme of things, as delineated in its multi-generational power-grab project, ‘One Belt, One Road’. What it wants is to turn the Middle East into a large oil and gas station by which it can fuel its economic growth to overtake the U.S. as the number one superpower by 2030. The three biggest oil and gas reserves in the region belong to Iran, Iraq, and Saudi Arabia, so it wants to control those to begin with. For Russia, which already has lots of oil and gas – over which China already has significant control – the objectives in the Middle East are more varied. One objective is to continue to exert influence in several countries that it regards as being key to maintaining some of its hold over the Former Soviet Union states. Another, more recent one, is to use this influence to bolster its position as a partner of note to China. As for the other countries in this soap opera –Iran, and Iraq, and now also more clearly, Saudi Arabia – they are in this new global alliance partly for the economic and political support from China (and to a lesser degree, Russia) and because their political systems are naturally much closer to the authoritarian regimes of China and Russia than they are to the democratic ones of the U.S. and its allies.

To the money shot, then, which was Iran and Iraq signing a new set of oil and gas agreements within the last two weeks. As also analysed in full in my new book on the new global oil market order, Iran has long exerted enormous influence over its neighbour directly and indirectly through its political, economic, and military proxies. Iraq was always pre-disposed to such cooperation in the energy sector, as the two countries share several of their biggest oil reservoirs. These include Azadegan (on the Iran side)/Majnoon (on the Iraq side), Azar/Badra, Yadavaran/Sinbad, Naft Shahr/Naft Khana, Dehloran/Abu Ghurab, West Paydar/Fakka and Arvand/South Abu Ghurab. This has long proven extremely useful to Iran in avoiding sanctions, as oil from its side of these reservoirs can easily be re-branded as non-sanctioned Iraqi oil and then shipped anywhere in the world. It has also proven a useful tool for Iraq through which it can extort billions of dollar from the U.S. by promising to stop the import of Iranian electricity and gas, only to renegue on those promises the second the money hits the downtown Baghdad bank accounts. The latest cooperation agreements strengthen all these ties between Iran-Iraq further.

Cue the other recent cooperation agreements aimed at making sure that whatever is Iran’s (including control over Iraq’s oil and gas reserves) it is also China’s and Russia’s. First up was Moscow, signing 10 new cooperation agreements with Iran for the oil sector alone on 18 May. According to a source who works closely with Iran’s Petroleum Ministry spoken to exclusively last week by OilPrice.com, the agreements comprise six memorandums of understanding, two contracts, one broader military cooperation roadmap, and another roadmap related to bilateral cooperation in the fields of industry, transfer of technology and oil recovery enhancement. In essence, these add up to a renewal and extension of the previous five-year and 10-year rolling agreements between Russia and Iran as also analysed in full in my new book. These allow Russia (together with China in separate agreements, to be covered in a moment) to have its firms present in any oil and gas field in Iran that Moscow chooses. It also allows for the exchange of the most promising military officers between the two countries and for Russia to have full access to Iran’s airports and seaports. Additionally, it allows for continued cooperation in other military and security matters, including intelligence, equipment and technology sharing. 

Russia’s man in Iran - Deputy Prime Minister and co-chair of the Permanent Russian-Iranian Commission on Trade and Economic Cooperation, Alexander Novak – stressed as well that the two countries are working on on banking interactions and using their national currencies in bilateral transactions. Further progress was also made on the North-South Transport Corridor (NSTC), with several agreements reached in the rail, road, maritime, and air transport sectors. Moscow is interested in developing the corridor all the way to India and beyond. Aside from boosting trade between Russia and Iran through the Caspian and Persian Gulf regions, these routes would also provide many opportunities for ‘dual purpose’ use – both civilian and military - of the airports and seaports.

Always looking to make a big entrance, China waited for the dust to settle before it too signed new cooperation agreements with Iran on 23 May. According to the Iran source spoken to by OilPrice.com, these agreements were simply nailing down some of the remaining details on financial, investment, and energy cooperation contained in the ‘Iran-China 25-Year Comprehensive Cooperation Agreement’ first revealed anywhere in the world in my 3 September 2019 article on the subject and covered in depth as well in my new book. In the 25-Year Agreement, China is guaranteed oil and gas prices from Iran at least 30 percent lower than the relevant oil pricing benchmarks. However, since the Russian invasion of Ukraine in February 2022, China has been demanding an extra discount on Iranian oil to the 30 percent discount at which it can currently also buy Russian oil, according to the Iran source. “On average, the Chinese discount for Iranian crude oil to the international benchmark over the last 12 months has been around 44 percent,” he said. “But, it is even worse for Iran, as – from 11 November 2022 - China has been paying Iran in non-convertible Yuan, that is Yuan that can only be used inside China and/or spent buying Chinese goods,” he added. “Worse still is that whilst Yuan is the key instrument in payment, China is also using the currencies of Angola, Zambia and Kenya to pay Iran, and China is doing this as a means to induce Iran to buys goods from these countries so that these countries, in turn, can service their loans to China,” he concluded.

https://www.zerohedge.com/markets/three-new-china-russia-iran-and-iraq-agreements-confirm-new-oil-market-order

Biohaven Details Clinical Progress, Regulatory Updates, and Pipeline Developments at R&D Day

 

  • Submitted a new drug application (NDA) for troriluzole in Spinocerebellar Ataxia Type 3 (SCA3) to U.S. FDA in 2Q2023, marking the team's fourth NDA in approximately 3 years

  • Released additional data from Kv7 platform, including Phase 1 safety data by dose groups for BHV-7000 that further validates differentiated profile

  • Projected Phase 3 Spinal Muscular Atrophy trial to complete enrollment in 2023

  • Initiated Phase 1 study of brain penetrant TYK2/JAK1 inhibitor, BHV-8000, and anticipate beginning Phase 2 trial in Parkinson's disease next year

  • Highlighted robust pipeline with multiple INDs planned to be filed within the next year, including pan IgG degrader for multiple immune-mediated diseases in 2023

Trends in Illicit Ketamine Seizures in the US From 2017 to 2022

 Joseph J. Palamar, PhD, MPH1Samuel T. Wilkinson, MD2Thomas H. Carr, BA3,4et al

doi:10.1001/jamapsychiatry.2023.1423

Abstract

Ketamine is a dissociative anesthetic that has been used in medicine for a half century, with recent trials demonstrating efficacy of esketamine (an enantiomer of ketamine) for treatment-resistant depression.1 In 2019, the US Food and Drug Administration approved the use of esketamine to treat this condition, although off-label use of racemic ketamine is now common.2 It is unclear whether extensive media coverage about the therapeutic benefits of ketamine and esketamine has influenced nonmedical or recreational use. In this cross-sectional study, we investigated seizures of illicit ketamine in the US from 2017 through 2022 as a measure of availability of ketamine for nonmedical use.

https://jamanetwork.com/journals/jamapsychiatry/article-abstract/2804864

EF Hutton Assumes Trxade Health at Buy

 With $1.25 Price Target

https://www.marketscreener.com/quote/stock/TRXADE-HEALTH-INC-15737465/news/EF-Hutton-Assumes-Trxade-Health-at-Buy-With-1-25-Price-Target-44016307/

Your favorite takeout joint is actually a catfishing scam — and it’s totally legal

 From the outside, Gourmet Deli at 90th Street and First Avenue seems like every other deli spread across the city.

On a typical morning, various locals pop in for bacon, egg and cheese bagel sandwiches and $1.50 drip coffee.

But, another wave of customers is flooding in through food delivery apps — only they don’t know they’re ordering from a bodega.

The deli located at 1741 First Avenue is advertised as no less than 27 different restaurants across Uber Eats, Postmates, Grubhub, Seamless and DoorDash.

On those platforms, it’s listed as First Avenue Gourmet DeliHero Sandwich ShopBosscat CheesesteaksThe Pancake SnobWraps on TapInsomnia Buffalo WingsPanini FantasyJasmine’s Coffee BarJen’s Burger BlazeNY Smoothie JointNomad’s BagelsTina’s Tea ShopAldo’s Wraps SpotWonderland WrapsSam’s Sandwich SpotSmoothie and Dessert SpotPrincess PaniniTessa’s Fruity TreatsEmpire State PaniniThe Sandwich SlutLa Bella Italian DessertsSeth’s SandwichesThe Sandwich VibeLV Taco BarQueen’s QuesadillasThe Gourmet Burger and Drip Check Coffee Shop.

MENU showing the Tuna Melts from  PRINCESS PANINI

Each spot has a cutesy name highlighting a type of food offered and variations of the same menu with different pricing.
MENU showing the Tuna Melts from EMPIRE STATE PANINI
The several virtual restaurants listed for First Avenue Gourmet Deli sell tuna melts for $16 or $17 while the deli prices theirs at $9.
MENU showing the Tuna Melts from Panini Fantasy
While the store names, photos, descriptions and prices all vary, all the tuna melts are being made in the same kitchen by the same staff.

Each spot has an eerily similar menu, but prices can differ — especially from the original outpost.

Princess Panini, Empire State Panini, and Panini Fantasy all offer a Tuna Melt Panini for $16 to $17. First Avenue Gourmet Deli sells theirs for $9.

During the pandemic, virtual restaurants — in which a single brick-and-mortar space operates a number of “delivery only” operations under different names — sprang up as businesses looked for new revenue streams. They rose alongside, and are often confused with, ghost kitchens, in which an existing restaurant is rented by a new crew to operate a delivery-only kitchen.

Both business models continue to exist — in a quick sweep, The Post found 10 delis across the five boroughs that operated, on average, eight different “restaurants” — but some customers say the virtual spots feel like false advertising.

In a viral thread on Twitter, numerous users weighed in to say they felt “tricked” to discover the restaurant they were ordering from was actually a chain restaurant or, worse, a gas station.

Counter at Gourmet Deli at 1471 First Avenue at 90th
Virtual restaurants are single brick-and-mortar spaces that operate a number of “delivery only” operations under different names while ghost kitchens are where a new crew rents out an existing restaurant to operate a delivery-only kitchen.
Tamara Beckwith

“‘Virtual Brand’ = always a no. Sorry if they’re great, I’ll never know. It seems irresponsible, like where is the chain of liability if someone gets sick from the food??” @ChismesYPuteria tweeted.

“Idk if this is misleading or straight up ‘scammy,'” @LutfilLeHadi said of the practice on Twitter.

The Post spoke to a manager at Gourmet Deli who said they were aware of the various online listings but not privy to details. They said the partner who manages the online brands was out of the country and could not be reached.

In some cases, a chain restaurant will list itself as a different brand to appeal to more customers. Denny’s, one of the country’s largest chains, also offers its menu, for delivery only, under the name the Meltdown.

Desserts at Gourmet Deli being sold by La Bella Italian Desserts
The desserts displayed in the casing at Gourmet Deli are sold online by La Bella Italian Desserts.
Tamara Beckwith

The Meltdown’s branding — “handcrafted sandwiches with attitude” — is quite distinct from Denny’s: “always open, always serving your favorites.”

Hospitality insiders note that virtual kitchens aren’t necessarily good for the industry.

“They add more competition to an already competitive marketplace and can harm existing restaurants,” Andrew Rigie, executive director of NYC Hospitality Alliance, told The Post. “If all of a sudden there’s multiple virtual brands competing with your brand online, it undercuts and undermines your business and makes it that much more difficult.”

Food safety is also a concern.

Most delis and bodegas in the city are classified as “stores,” “supermarkets” and “food manufacturers,” and regulated by New York State’s Department of Agriculture and Markets not the Department of Health and Mental Hygiene.

Inside Gourment Deli at 1471 First Avenue at 90th Street.
Customers and restauranteurs have concerns about the health and safety of these establishments noting that most delis and bodegas in the city are classified as “stores,” “supermarkets” and “food manufacturers,” and regulated by New York State’s Department of Agriculture and Markets not the Department of Health and Mental Hygiene.
Tamara Beckwith

As such, they are not subject to the same letter grades and inspections as traditional restaurants.

Delivery platforms have, for the most part, allowed — and in some cases even encouraged — virtual restaurants to proliferate.

On its website, Grubhub, which owns Seamless, promotes virtual restaurants as “the food industry’s secret weapon” that “boost profits” by allowing companies to “capture new business with very low risk.”

DoorDash’s website says that virtual kitchens offer “operators new opportunities to expand their business” by driving additional sales and enabling “restaurants to provide consistent shifts to their employees.”

Uber Eats, however, recently announced plans to crack down on the practice and remove 5,000 online storefronts.

It’s a “Wild West, anything goes kind of situation,” Uber Eats’ John Mullenholz told the Wall Street Journal. “It’s fair to say that kind of erodes consumer confidence.”

But, some people are happy so long as the meals are good.

“Whatever man,” Twitter user @rayRich77744950 said. “Is the food good? Did you die? Alright then. Gone order. Shiiiidddd.”

https://nypost.com/2023/06/01/nyc-delis-use-seamless-doordash-grubhub-to-pose-as-restaurants/

Obesity Shot Frenzy Makes Lilly World’s Most Valuable Drugmaker

 Eli Lilly & Co.’s (LLY) third straight month of gains has helped it become the largest pharmaceutical company in the world by market value, surpassing Johnson & Johnson.

An 8.5% gain in May for Lilly lifted its shares to a record high and pushed its market capitalization to about $408 billion. J&J, meanwhile, slumped 5.3% during the month, dragging its value down to $403 billion. The Lilly rally was fueled in large part by two major announcements. The first was that its new diabetes drug worked for obesity, followed shortly by news that its experimental treatment for Alzheimer’s succeeded in a final-stage trial.

“Lilly is participating in arguably the two areas of therapeutics that investors are kind of most interested in,” Jared Holz, a managing director at Mizuho Securities, said in an interview. “The street is essentially saying that they’re willing to ascribe very significant value for the large market opportunities and then very little for what they believe are more niche.”

In late April, Lilly said that diabetes drug Mounjaro had succeeded in a second final-stage trial in obesity. Approval would open up an vast new market for the drug, allowing it to go head-to-head with Novo Nordisk A/S’s Wegovy, the leading GLP-1 drug approved for weight loss.

Read More: Obesity Drug Hit Makes Novo Nordisk More Valuable Than Nestle

Meanwhile, Novo Nordisk’s market value has more than doubled since the start of 2021 amid the popularity of its new GLP-1 drugs for diabetes and obesity. In March, it became the second-most valuable company in Europe, knocking Swiss food conglomerate Nestle SA into third place.

One trial showed that patients who take the highest dose of Mounjaro lost an average of 50 pounds. Analysts estimate its annual sales will approach $18 billion by 2029, according to figures compiled by Bloomberg.

Lilly also plans to apply this quarter for approval of its Alzheimer’s drug donanemab, after a late-stage trial showed it was capable of modifying the disease course of the most common form of dementia — only the second drug to to so. The therapy removes an abnormal protein, called amyloid, from the brains of Alzheimer’s patients and would compete with Eisai Co.’s Leqembi.

“Over the past like five to 10 years, when people talk about pharma, they kind of always lead with Pfizer, J&J, Merck,” Holz said. “Lilly is like fourth or fifth maybe, and now it’s first. So a reassortment of the standings I think, is meaningful.”

J&J’s spinoff of its consumer health unit into a new company earlier this year has been the biggest hit to its shares, according to Holz, which have fallen 12% this year. The company could regain at least some of its value with purchases, he said.

Losing its leading position “could put a little bit more pressure or urgency on the part of J&J to augment both its medical device and pharmaceuticals businesses over time,” Holz said.

https://finance.yahoo.com/news/obesity-shot-frenzy-makes-eli-202643499.html

US issues sanctions against Iranian officials in response to assassination plots

 The United States has implemented sanctions against several individuals who are members of or associated with the Iranian military who have been involved in “a series of terrorist plots.” 

The Treasury Department said in a release on Thursday that it is targeting three individuals and a company affiliated with the Iranian Islamic Revolutionary Guard Corps (IRGC) Qods Force and two senior officials for the IRGC’s Intelligence Organization.

The release states that the individuals have been involved in assassination plots against former U.S. government officials, dual U.S. and Iranian nationals and Iranian dissidents. 

“The United States remains focused on disrupting plots by the IRGC and its Qods Force, both of which have engaged in numerous assassination attempts and other acts of violence and intimidation against those they deem enemies of the Iranian regime,” Under Secretary of the Treasury for Terrorism and Financial Intelligence Brian Nelson said in the release. 

The release notes that the Treasury Department has previously addressed terrorist plots from the IRGC’s Qods Force and Intelligence Organization, including an October 2011 designation of top officials involved in planning to assassinate the Saudi Arabian ambassador to the U.S. and the December 2020 designation of an individual involved in plans to carry out operations in the Middle East and United States. 

The department also sanctioned Iranian intelligence agents in September 2021 who targeted a U.S. citizen and Iranian dissidents in other countries. 

The release states Mohammad Reza Ansari, one sanctioned official who is a long-term member of the Qods Force, is also a member of a unit that undertakes operations against Iranian dissidents and non-Iranian nationals in other countries. Ansari and Iranian national Shahram Poursafi planned and tried to assassinate two former U.S. officials. 

Hossein Hafez Amini, a dual Iranian-Turkish national, has used his Turkey-based airline to help the Qods Force’s operations, including kidnapping and assassination schemes, according to the release. 

Former IRGC Intelligence Organization counterespionage official Rouhallah Bazghandi has been involved in overseeing plans to assassinate journalists and Israeli nationals in Istanbul, while Foreign Intelligence Chief Reza Seraj has been involved in failed operations in Asia and operations targeting U.S. citizens.

https://thehill.com/policy/international/4030196-us-issues-sanctions-against-iranian-officials-in-response-to-assassination-plots/